Initially, we examined how BATF2 expression affected survival in GBM patients using the publicly available The Cancer Genome Atlas-GBM dataset and found that higher BATF2 transcript correlated with increased survival (Fig. 6A). This evidence concerns the gene BATF2 and cancer.